Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Down 55.6% in June

Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) was the target of a large decrease in short interest in June. As of June 30th, there was short interest totaling 51,538 shares, a decrease of 55.6% from the June 15th total of 116,151 shares. Based on an average trading volume of 345,299 shares, the short-interest ratio is presently 0.1 days.

Analyst Ratings Changes

Separately, Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Siemens Healthineers currently has a consensus rating of “Moderate Buy”.

Get Siemens Healthineers alerts:

Get Our Latest Stock Report on Siemens Healthineers

Siemens Healthineers Trading Down 2.7%

OTCMKTS SMMNY traded down $0.54 during trading on Tuesday, reaching $19.54. 117,677 shares of the company’s stock traded hands, compared to its average volume of 165,301. Siemens Healthineers has a 12-month low of $19.32 and a 12-month high of $28.92. The company’s 50 day simple moving average is $19.89 and its two-hundred day simple moving average is $22.40.

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.

Featured Stories

• Five stocks we like better than Siemens Healthineers
• 3 Space Stocks That Could Outshine SpaceX After Its IPO
• JPMorgan’s Q2 Strength Gives the Stock Rally New Support
• 3 Energy Stocks Racing to Fix AI’s Power Problem
• No Space For Panic: T-Mobile Shrugs Off The Starlink Threat

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.